The Effect of Antiemetics on Bowel Preparation Before Colonoscopy
Launched by RENJI HOSPITAL · Oct 4, 2020
Trial Information
Current as of June 18, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-70 years patients scheduled for colonoscopy
- Exclusion Criteria:
- • intestinal obstruction or hemorrhage;
- • allergy to domperidone, sulpiride or PEG;
- • pregnancy or breastfeeding;
- • previous use of prokinetics within 1 month.
About Renji Hospital
Renji Hospital, a prestigious medical institution affiliated with Shanghai Jiao Tong University School of Medicine, is dedicated to advancing healthcare through innovative clinical research. With a strong emphasis on patient-centered care, Renji Hospital conducts a wide range of clinical trials across various therapeutic areas, harnessing cutting-edge technology and evidence-based practices. The hospital's multidisciplinary team of experienced researchers and medical professionals collaborates closely to ensure rigorous study design and execution, aiming to contribute significantly to medical knowledge and improve treatment outcomes for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, , China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials